{"protocolSection":{"identificationModule":{"nctId":"NCT04797013","orgStudyIdInfo":{"id":"MK02-2020-01"},"organization":{"fullName":"Beijing Tiantan Hospital","class":"OTHER"},"briefTitle":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ","officialTitle":"A Phase 3, Multicentre,Open-label, Randomised Controlled, Non-inferiority Trial","acronym":"TRACEⅡ"},"statusModule":{"statusVerifiedDate":"2023-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-06-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-05-29","type":"ACTUAL"},"completionDateStruct":{"date":"2022-07-15","type":"ACTUAL"},"studyFirstSubmitDate":"2021-02-25","studyFirstSubmitQcDate":"2021-03-10","studyFirstPostDateStruct":{"date":"2021-03-15","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-01-13","lastUpdatePostDateStruct":{"date":"2023-01-17","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Yongjun Wang","investigatorTitle":"President of Beijing Tiantan Hospital, Capital Medical University, Director of Neurology Center","investigatorAffiliation":"Beijing Tiantan Hospital"},"leadSponsor":{"name":"Beijing Tiantan Hospital","class":"OTHER"},"collaborators":[{"name":"Guangzhou Recomgen Biotech Co., Ltd.","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A Phase Ⅲ, Multicenter, Prospective, Randomized, Open Label, Blinded-endpoint (PROBE) Controlled Trial of Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) for Injection Versus Alteplase for Acute Ischemic Stroke Within 4.5 Hours","detailedDescription":"To test the hypothesis that rhTNK-tPA is non-inferior to alteplase in thrombolysis treatment when administered within 4.5 hours of ischemic stroke onset."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"],"keywords":["rhTNK-tPA","acute","stroke","phaseⅢ","Acute Ischemic Stroke","rt-PA"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"multicenter, prospective, randomized, open label, blinded-endpoint (PROBE)，Parallel controls，Non-inferiority","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1430,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"rhTNK-tPA (0.25mg/kg)","type":"ACTIVE_COMPARATOR","description":"rhTNK-tPA (0.25mg/kg) is given as a single, intravenous bolus (within 5-10 seconds) immediately upon randomization. Maximum dose 25mg.","interventionNames":["Drug: rhTNK-tPA"]},{"label":"rt-PA (0.9mg/kg)","type":"ACTIVE_COMPARATOR","description":"10% dose of rt-PA (0.9 mg/kg) is given as bolus and the remainder in 1 hour. Maximum dose 90mg.","interventionNames":["Drug: rt-PA"]}],"interventions":[{"type":"DRUG","name":"rt-PA","description":"Subjects will be randomized to rhTNK-tPA or rt-PA in a 1:1 ratio.","armGroupLabels":["rt-PA (0.9mg/kg)"],"otherNames":["Alteplase injection (rt-PA)"]},{"type":"DRUG","name":"rhTNK-tPA","description":"Subjects will be randomized to rhTNK-tPA or rt-PA in a 1:1 ratio.","armGroupLabels":["rhTNK-tPA (0.25mg/kg)"],"otherNames":["Recombinant Human TNK Tissue-type Plasminogen Activator for Injection"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Excellent functional outcome","description":"Proportion of subjects with mRS(0-1) at 90 days.","timeFrame":"90 days"}],"secondaryOutcomes":[{"measure":"Good functional outcome","description":"Proportion of subjects with mRS(0-2) at 90 days.","timeFrame":"90 days"},{"measure":"National Institutes of Health Stroke Scale (NIHSS)","description":"Proportion of subjects with NIHSS score ≥ 4 improved compared with baseline at 24 or with NIHSS 0-1 at 24 hours and 7 days.","timeFrame":"24 hours，day7"},{"measure":"EQ-5D","description":"Quality of life measured by EQ-5D scale.","timeFrame":"90 days"},{"measure":"Barthel (BI)","description":"Global function of daily living defined as BI ≥ 95 at 90 days.","timeFrame":"90 days"},{"measure":"Modified Rankin Scale(mRS)","description":"Ordinal distribution of mRS at 90 days.","timeFrame":"90 days"}],"otherOutcomes":[{"measure":"Symptomatic intracranial hemorrhage(sICH)","description":"Proportion of subjects with symptomatic intracranial hemorrhage (sICH) at 36 hours.( defined by ECASSIII)","timeFrame":"36 hours"},{"measure":"Asymptomatic intracranial hemorrhage","description":"The incidence of asymptomatic intracranial hemorrhage at 90 days.","timeFrame":"90 days"},{"measure":"PH2 intracranial hemorrhage","description":"The incidence of PH2 intracranial hemorrhage within 90 days (according to SITS standards).","timeFrame":"90 days"},{"measure":"Any intracranial hemorrhage","description":"The incidence of any intracranial hemorrhage within 90 days.","timeFrame":"90 days"},{"measure":"Systematic bleeding","description":"The incidence of Systematic bleeding at 90 days.( defined by GUSTO）","timeFrame":"90 days"},{"measure":"Deaths","description":"Rate of Overall mortality at 90 days.","timeFrame":"90 days"},{"measure":"AEs/SAEs","description":"The incidence of adverse events(AEs) / severe adverse events(SAEs) at 90 days.","timeFrame":"90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥18 years old, no gender limitation;\n* The time from onset to treatment was \\< 4.5h;The time at which symptoms begin is defined as \"the time at which they finally appear normal\";\n* The clinical diagnosis was ischemic stroke (the diagnosis followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018);\n* MRS before onset was 0-1 points\n* Baseline NIHSS 5-25(both included);\n* Informed consent from the patient or surrogate.\n\nExclusion Criteria:\n\n* Intended to proceed endovascular treatment;\n* NIHSS consciousness score \\>2;\n* Allergy to tenecteplase or alteplase;\n* Past history of intracranial hemorrhage ;\n* A history of severe head trauma or stroke within 3 months;\n* A history of intracranial or spinal surgery within 3 months;\n* A history of gastrointestinal or urinary bleeding within 3 weeks;\n* 2 weeks of major surgery;\n* Arterial puncture was performed at the hemostasis site that was not easily compressed within 1 week;\n* Intracranial tumors (except neuroectodermal tumors, such as meningiomas), large intracranial aneurysms;\n* Intracranial hemorrhage (including parenchymal hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, subdural/extradural hematoma, etc.);\n* Active visceral bleeding;\n* Aortic arch dissection was found;\n* After active antihypertensive treatment, hypertension is still not under control: systolic blood pressure ≥180 mm Hg, or diastolic blood pressure ≥100 mm Hg;\n* Propensity for acute bleeding, including platelet counts of less than 100×109/ L or otherwise;\n* Blood glucose \\<2.8 mmol/L or \\>22.22 mmol/L;\n* Oral warfarin anticoagulant with INR\\>1.7 or PT\\>15 s;\n* Heparin treatment was received within 24 h;\n* Thrombin inhibitors or factor Xa inhibitors were used within 48 h;\n* Head CT or MRI showed a large infarction (infarcted area \\> 1/3 of the middle cerebral artery);\n* Subjects who are unable or unwilling to cooperate due to hemiplegia (Todd's palsy) after epileptic seizure or other neurological/psychiatric disorders;\n* Pregnant women, lactating women, or subjects who do not agree to use effective contraception during the trial;\n* Participation in other clinical trials within 3 months prior to screening;\n* Unsuitability or participation in this study as judged by the Investigator may result in subjects being exposed to greater risk.","healthyVolunteers":false,"sex":"ALL","genderBased":true,"minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Wei Sun","affiliation":"IRB of Beijing Tiantan Hospital,Capital Medical University","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"The first affiliated hospital of ustc","city":"Hefei","state":"Anhui","zip":"230000","country":"China","geoPoint":{"lat":31.86389,"lon":117.28083}},{"facility":"The people's hospltal of xuancheng city","city":"Xuancheng","state":"Anhui","zip":"242000","country":"China","geoPoint":{"lat":25.40949,"lon":116.3841}},{"facility":"Beijing luhe hospital capital medical university","city":"Beijing","state":"Beijing","zip":"100000","country":"China","geoPoint":{"lat":39.9075,"lon":116.39723}},{"facility":"Beijing Tiantan Hospital, Capital Medical University","city":"Beijing","state":"Beijing","zip":"100000","country":"China","geoPoint":{"lat":39.9075,"lon":116.39723}},{"facility":"Chongqing Three Gorges Central Hospital","city":"Chongqing","state":"Chongqing","zip":"404100","country":"China","geoPoint":{"lat":29.56278,"lon":106.55278}},{"facility":"The first hospital of lanzhou university","city":"Lanzhou","state":"Gansu","zip":"730000","country":"China","geoPoint":{"lat":36.05701,"lon":103.83987}},{"facility":"Guangdong Provincial Hospital of Traditional Chinese Medicine","city":"Guangdong","state":"Guangdong","zip":"510000","country":"China"},{"facility":"Yue bei people's hospital","city":"Shaoguan","state":"Guangdong","zip":"512000","country":"China","geoPoint":{"lat":24.8,"lon":113.58333}},{"facility":"Guizhou provincial people's hospital","city":"Guiyang","state":"Guizhou","zip":"550000","country":"China","geoPoint":{"lat":26.58333,"lon":106.71667}},{"facility":"Affiliated hospital of chengde medical university","city":"Chengde","state":"Hebei","zip":"067000","country":"China","geoPoint":{"lat":40.9519,"lon":117.95883}},{"facility":"The first hospital of hebei medical university","city":"Shijiazhuang","state":"Hebei","zip":"050000","country":"China","geoPoint":{"lat":38.04139,"lon":114.47861}},{"facility":"the Third Hospital of Hebei Medical University","city":"Shijiazhuang","state":"Hebei","zip":"050000","country":"China","geoPoint":{"lat":38.04139,"lon":114.47861}},{"facility":"Tangshan Workers ' Hospital","city":"Tangshan","state":"Hebei","zip":"063000","country":"China","geoPoint":{"lat":39.63333,"lon":118.18333}},{"facility":"The first affiliated hospital of hebei north university","city":"Zhangjiakou","state":"Hebei","zip":"075000","country":"China","geoPoint":{"lat":40.81,"lon":114.87944}},{"facility":"Daqing Oilfield General Hospital","city":"Daqing","state":"Heilongjiang","zip":"163000","country":"China","geoPoint":{"lat":46.58333,"lon":125.0}},{"facility":"The 2ad affiliated hospital of harbin medical university","city":"Haerbin","state":"Heilongjiang","zip":"150000","country":"China","geoPoint":{"lat":31.8696,"lon":101.742}},{"facility":"Second People's Hospital of Jiaozuo City","city":"Jiaozuo","state":"Henan","zip":"454150","country":"China","geoPoint":{"lat":35.23972,"lon":113.23306}},{"facility":"Nanyang central hospital","city":"Nanyang","state":"Henan","zip":"473000","country":"China","geoPoint":{"lat":32.99472,"lon":112.53278}},{"facility":"Nanyang Nanshi Hospital","city":"Nanyang","state":"Henan","zip":"473000","country":"China","geoPoint":{"lat":32.99472,"lon":112.53278}},{"facility":"Nayang second general hospital","city":"Nanyang","state":"Henan","zip":"473000","country":"China","geoPoint":{"lat":32.99472,"lon":112.53278}},{"facility":"Pingmei Shenma Medical Group General Hospital","city":"Pingdingshan","state":"Henan","zip":"467000","country":"China","geoPoint":{"lat":33.73847,"lon":113.30119}},{"facility":"Xinxiang first people's hospital","city":"Xinxiang","state":"Henan","zip":"453000","country":"China","geoPoint":{"lat":35.19033,"lon":113.80151}},{"facility":"Xinyang central hospital","city":"Xinyang","state":"Henan","zip":"464000","country":"China","geoPoint":{"lat":32.12278,"lon":114.06556}},{"facility":"The first affiliated hospital of zhengzhou university","city":"Zhengzhou","state":"Henan","zip":"450000","country":"China","geoPoint":{"lat":34.75778,"lon":113.64861}},{"facility":"The central hospital of wuhan","city":"Wuhan","state":"Hunan","zip":"430000","country":"China","geoPoint":{"lat":30.58333,"lon":114.26667}},{"facility":"Inner Mongolia Baotou Hospita","city":"Baotou","state":"Inner Mongolia","zip":"014","country":"China","geoPoint":{"lat":40.65222,"lon":109.82222}},{"facility":"Affiliated Hospital of Chifeng University","city":"Chifeng","state":"Inner Mongolia","zip":"024000","country":"China","geoPoint":{"lat":42.26833,"lon":118.96361}},{"facility":"Kashkten Mongolian Medicine Hospital","city":"Chifeng","state":"Inner Mongolia","zip":"024000","country":"China","geoPoint":{"lat":42.26833,"lon":118.96361}},{"facility":"Inner Mongolia People'S Hospital","city":"Hohhot","state":"Inner Mongolia","zip":"010000","country":"China","geoPoint":{"lat":40.81056,"lon":111.65222}},{"facility":"Huai an second people's hospital","city":"Huaian","state":"Jiangsu","zip":"223001","country":"China","geoPoint":{"lat":33.50389,"lon":119.14417}},{"facility":"Jiangsu taizhou people's hopital","city":"Taizhou","state":"Jiangsu","zip":"225300","country":"China","geoPoint":{"lat":32.49069,"lon":119.90812}},{"facility":"General Hospital of Xuzhou Mining Group","city":"Xuzhou","state":"Jiangsu","zip":"221000","country":"China","geoPoint":{"lat":34.18045,"lon":117.15707}},{"facility":"Xuzhou central hospital","city":"Xuzhou","state":"Jiangsu","zip":"221000","country":"China","geoPoint":{"lat":34.18045,"lon":117.15707}},{"facility":"Third Affiliated Hospital of Nanchang University","city":"Nanchang","state":"Jiangxi","zip":"330000","country":"China","geoPoint":{"lat":28.68396,"lon":115.85306}},{"facility":"First Hospital of Jilin University","city":"Changchun","state":"Jilin","zip":"130","country":"China","geoPoint":{"lat":43.88,"lon":125.32278}},{"facility":"Jilin neuropsychiaric hospital","city":"Siping","state":"Jilin","zip":"136000","country":"China","geoPoint":{"lat":43.16143,"lon":124.37785}},{"facility":"Tonghua Central Hospital","city":"Tonghua","state":"Jilin","zip":"134000","country":"China","geoPoint":{"lat":41.71972,"lon":125.92639}},{"facility":"Meihekou Central Hospital","city":"Tonghua","state":"Jilin","zip":"135000","country":"China","geoPoint":{"lat":41.71972,"lon":125.92639}},{"facility":"The Firet Affiliated Hospital of Jinzhou Medical University","city":"Jinzhou","state":"Liaoning","zip":"121000","country":"China","geoPoint":{"lat":41.10778,"lon":121.14167}},{"facility":"Central hospital affiliated to shenyang medical college","city":"Shenyang","state":"Liaoning","zip":"110000","country":"China","geoPoint":{"lat":41.79222,"lon":123.43278}},{"facility":"General Hospital of Northern War Zone, PLA","city":"Shenyang","state":"Liaoning","zip":"110000","country":"China","geoPoint":{"lat":41.79222,"lon":123.43278}},{"facility":"The first hospital of china medical university","city":"Shenyang","state":"Liaoning","zip":"110000","country":"China","geoPoint":{"lat":41.79222,"lon":123.43278}},{"facility":"The First People'S Hospital of Shenyang","city":"Shenyang","state":"Liaoning","zip":"110000","country":"China","geoPoint":{"lat":41.79222,"lon":123.43278}},{"facility":"Linyi City People Hospital","city":"Linyi","state":"Shandong","zip":"276000","country":"China","geoPoint":{"lat":35.06306,"lon":118.34278}},{"facility":"Tengzhou Central People's Hospital","city":"Tengzhou","state":"Shandong","zip":"277559","country":"China","geoPoint":{"lat":35.08357,"lon":117.19071}},{"facility":"Yantai Yuhuangding Hosopital","city":"Yantai","state":"Shandong","zip":"264000","country":"China","geoPoint":{"lat":37.47649,"lon":121.44081}},{"facility":"Huashan Hospital Affiliated to Fudan University","city":"Shanghai","state":"Shanghai","zip":"200000","country":"China","geoPoint":{"lat":31.22222,"lon":121.45806}},{"facility":"Heping hospital affiliated to changzhi medical college","city":"Changzhi","state":"Shanxi","zip":"046000","country":"China","geoPoint":{"lat":35.20889,"lon":111.73861}},{"facility":"General Hospital of Chinese Medicine and Coal","city":"Datong","state":"Shanxi","zip":"037000","country":"China","geoPoint":{"lat":40.09361,"lon":113.29139}},{"facility":"The fifth people's s hospital of datong","city":"Datong","state":"Shanxi","zip":"037000","country":"China","geoPoint":{"lat":40.09361,"lon":113.29139}},{"facility":"Linfen central hospital","city":"Linfen","state":"Shanxi","zip":"041000","country":"China","geoPoint":{"lat":36.08889,"lon":111.51889}},{"facility":"Linfen people's hospital","city":"Linfen","state":"Shanxi","zip":"041000","country":"China","geoPoint":{"lat":36.08889,"lon":111.51889}},{"facility":"First Hospital of Shanxi Medical University","city":"Taiyuan","state":"Shanxi","zip":"030000","country":"China","geoPoint":{"lat":37.86944,"lon":112.56028}},{"facility":"Shanxi Cardiovascular Hospital","city":"Taiyuan","state":"Shanxi","zip":"030000","country":"China","geoPoint":{"lat":37.86944,"lon":112.56028}},{"facility":"Xianyang Hospital of Yan ' an University","city":"Xianyang","state":"Shanxi","zip":"712000","country":"China","geoPoint":{"lat":34.33778,"lon":108.70261}},{"facility":"Mianyang central hospital","city":"Mianyang","state":"Sichuan","zip":"621000","country":"China","geoPoint":{"lat":31.46784,"lon":104.68168}},{"facility":"Shanxi provincial prople's hospital","city":"Taiyuan","state":"Taiyuan","zip":"030000","country":"China","geoPoint":{"lat":37.86944,"lon":112.56028}},{"facility":"The Second Affiliated Hospital Zhejiang University School of Medicine","city":"Hangzhou","state":"Zhejiang","zip":"310000","country":"China","geoPoint":{"lat":30.29365,"lon":120.16142}},{"facility":"Lishui Central Hospital","city":"Lishui","state":"Zhejiang","zip":"323000","country":"China","geoPoint":{"lat":28.46042,"lon":119.91029}},{"facility":"Taizhou Enze Medical Center ( Group )","city":"Taizhou","state":"Zhejiang","zip":"318000","country":"China","geoPoint":{"lat":32.49069,"lon":119.90812}},{"facility":"Wenzhou Central Hospital","city":"Wenzhou","state":"Zhejiang","zip":"325000","country":"China","geoPoint":{"lat":27.99942,"lon":120.66682}}]},"referencesModule":{"references":[{"pmid":"32078683","type":"BACKGROUND","citation":"Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O'Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O'Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Part 2 investigators. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial. JAMA. 2020 Apr 7;323(13):1257-1265. doi: 10.1001/jama.2020.1511. Erratum In: JAMA. 2022 Mar 8;327(10):985."},{"pmid":"31318627","type":"BACKGROUND","citation":"Burgos AM, Saver JL. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials. Stroke. 2019 Aug;50(8):2156-2162. doi: 10.1161/STROKEAHA.119.025080. Epub 2019 Jul 18."},{"pmid":"18815396","type":"BACKGROUND","citation":"Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656."},{"pmid":"31128925","type":"BACKGROUND","citation":"Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, Leys D, Molina C, Wijeratne T, Curtze S, Dewey HM, Barber PA, Butcher KS, De Silva DA, Bladin CF, Yassi N, Pfaff JAR, Sharma G, Bivard A, Desmond PM, Schwab S, Schellinger PD, Yan B, Mitchell PJ, Serena J, Toni D, Thijs V, Hacke W, Davis SM, Donnan GA; EXTEND, ECASS-4, and EPITHET Investigators. Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019 Jul 13;394(10193):139-147. doi: 10.1016/S0140-6736(19)31053-0. Epub 2019 May 22. Erratum In: Lancet. 2020 Jun 20;395(10241):1906."},{"pmid":"25106063","type":"BACKGROUND","citation":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29;384(9958):1929-35. doi: 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5."},{"pmid":"32943483","type":"BACKGROUND","citation":"Kunz WG, Hunink MG, Almekhlafi MA, Menon BK, Saver JL, Dippel DWJ, Majoie CBLM, Jovin TG, Davalos A, Bracard S, Guillemin F, Campbell BCV, Mitchell PJ, White P, Muir KW, Brown S, Demchuk AM, Hill MD, Goyal M; HERMES Collaborators. Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke. Neurology. 2020 Nov 3;95(18):e2465-e2475. doi: 10.1212/WNL.0000000000010867. Epub 2020 Sep 17."},{"pmid":"25726502","type":"BACKGROUND","citation":"Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, Ford I, Muir KW. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015 Apr;14(4):368-76. doi: 10.1016/S1474-4422(15)70017-7. Epub 2015 Feb 26."},{"pmid":"28780236","type":"BACKGROUND","citation":"Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Ronning OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, Tobro H, Kaur K, Stankiewicz M, Carlsson M, Morsund A, Idicula T, Aamodt AH, Lund C, Naess H, Waje-Andreassen U, Thomassen L. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017 Oct;16(10):781-788. doi: 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2."},{"pmid":"30117036","type":"BACKGROUND","citation":"Kheiri B, Osman M, Abdalla A, Haykal T, Ahmed S, Hassan M, Bachuwa G, Al Qasmi M, Bhatt DL. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2018 Nov;46(4):440-450. doi: 10.1007/s11239-018-1721-3."},{"pmid":"31662117","type":"RESULT","citation":"Warner JJ, Harrington RA, Sacco RL, Elkind MSV. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019 Dec;50(12):3331-3332. doi: 10.1161/STROKEAHA.119.027708. Epub 2019 Oct 30. No abstract available."},{"pmid":"29367334","type":"RESULT","citation":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24. Erratum In: Stroke. 2018 Mar;49(3):e138. Stroke. 2018 Apr 18;:"},{"pmid":"32561535","type":"RESULT","citation":"Liu L, Chen W, Zhou H, Duan W, Li S, Huo X, Xu W, Huang L, Zheng H, Liu J, Liu H, Wei Y, Xu J, Wang Y; Chinese Stroke Association Stroke Council Guideline Writing Committee. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol. 2020 Jun;5(2):159-176. doi: 10.1136/svn-2020-000378. Epub 2020 Jun 18."},{"pmid":"31067369","type":"RESULT","citation":"Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019 May 9;380(19):1795-1803. doi: 10.1056/NEJMoa1813046. Erratum In: N Engl J Med. 2021 Apr 1;384(13):1278."},{"pmid":"29766770","type":"RESULT","citation":"Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, Gunther M, Guibernau J, Hausler KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C; WAKE-UP Investigators. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med. 2018 Aug 16;379(7):611-622. doi: 10.1056/NEJMoa1804355. Epub 2018 May 16."},{"pmid":"27462117","type":"RESULT","citation":"Seners P, Turc G, Maier B, Mas JL, Oppenheim C, Baron JC. Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis. Stroke. 2016 Sep;47(9):2409-12. doi: 10.1161/STROKEAHA.116.014181. Epub 2016 Jul 26."},{"pmid":"25671798","type":"RESULT","citation":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015 Mar 12;372(11):1019-30. doi: 10.1056/NEJMoa1414905. Epub 2015 Feb 11."},{"pmid":"25882510","type":"RESULT","citation":"Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Roman L, Serena J, Abilleira S, Ribo M, Millan M, Urra X, Cardona P, Lopez-Cancio E, Tomasello A, Castano C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Perez M, Goyal M, Demchuk AM, von Kummer R, Gallofre M, Davalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015 Jun 11;372(24):2296-306. doi: 10.1056/NEJMoa1503780. Epub 2015 Apr 17."},{"pmid":"25882376","type":"RESULT","citation":"Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnil de Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015 Jun 11;372(24):2285-95. doi: 10.1056/NEJMoa1415061. Epub 2015 Apr 17."},{"pmid":"25517348","type":"RESULT","citation":"Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama a Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 Jan 1;372(1):11-20. doi: 10.1056/NEJMoa1411587. Epub 2014 Dec 17. Erratum In: N Engl J Med. 2015 Jan 22;372(4):394."},{"pmid":"25671797","type":"RESULT","citation":"Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015 Mar 12;372(11):1009-18. doi: 10.1056/NEJMoa1414792. Epub 2015 Feb 11."},{"pmid":"26898852","type":"RESULT","citation":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millan M, Davis SM, Roy D, Thornton J, Roman LS, Ribo M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X. Epub 2016 Feb 18."},{"pmid":"32562685","type":"RESULT","citation":"Fassbender K, Walter S, Grunwald IQ, Merzou F, Mathur S, Lesmeister M, Liu Y, Bertsch T, Grotta JC. Prehospital stroke management in the thrombectomy era. Lancet Neurol. 2020 Jul;19(7):601-610. doi: 10.1016/S1474-4422(20)30102-2."},{"pmid":"24324944","type":"RESULT","citation":"Bivard A, Lin L, Parsonsb MW. Review of stroke thrombolytics. J Stroke. 2013 May;15(2):90-8. doi: 10.5853/jos.2013.15.2.90. Epub 2013 May 31."},{"pmid":"22435369","type":"RESULT","citation":"Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O'Brien B, Bladin C, McElduff P, Allen C, Bateman G, Donnan G, Davis S, Levi C. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012 Mar 22;366(12):1099-107. doi: 10.1056/NEJMoa1109842."},{"pmid":"25677596","type":"RESULT","citation":"Coutts SB, Dubuc V, Mandzia J, Kenney C, Demchuk AM, Smith EE, Subramaniam S, Goyal M, Patil S, Menon BK, Barber PA, Dowlatshahi D, Field T, Asdaghi N, Camden MC, Hill MD; TEMPO-1 Investigators. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion. Stroke. 2015 Mar;46(3):769-74. doi: 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12."},{"pmid":"29694815","type":"RESULT","citation":"Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi CR, Rodrigues E, Zhao H, Salvaris P, Garcia-Esperon C, Bailey P, Rice H, de Villiers L, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Wong AA, Muller C, Coulthard A, Mitchell K, Clouston J, Mahady K, Field D, Ma H, Phan TG, Chong W, Chandra RV, Slater LA, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Investigators. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018 Apr 26;378(17):1573-1582. doi: 10.1056/NEJMoa1716405."},{"pmid":"34446531","type":"DERIVED","citation":"Li S, Campbell BCV, Schwamm LH, Fisher M, Parsons M, Li H, Pan Y, Wang Y; TRACE II investigators. Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design. Stroke Vasc Neurol. 2022 Feb;7(1):71-76. doi: 10.1136/svn-2021-001074. Epub 2021 Aug 26."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Acute Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000010959","term":"Tissue Plasminogen Activator"},{"id":"D000010958","term":"Plasminogen"}],"ancestors":[{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M13539","name":"Tissue Plasminogen Activator","asFound":"Feed-back","relevance":"HIGH"},{"id":"M1911","name":"Tenecteplase","relevance":"LOW"},{"id":"M13538","name":"Plasminogen","asFound":"Health-related Quality of Life","relevance":"HIGH"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}